| O.1 | Approve Financial Statements and Statutory Reports | For |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports | For |
| O.3 | Approve Allocation of Income and Absence of Dividends | For |
| O.4 | Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions | For |
| O.5 | Approve Compensation of Report of Corporate Officers | Oppose |
| O.6 | Approve Compensation of Paul Boudre, CEO | Oppose |
| O7 | Approve Compensation of Eric Meurice, Chair of the Board | For |
| O.8 | Approve Remuneration Policy of Executive Corporate Officers | Abstain |
| O.9 | Approve Remuneration of Directors in the Aggregate Amount of EUR 780,000 | For |
| O.10 | Authorise Share Repurchase | Oppose |
| E.11 | Amend Article 12 of Bylaws Re: Employee Representative | For |
| E.12 | Authorize Issuance of Equity or Equity-Linked Securities with Pre-emptive Rights up to Aggregate Nominal Amount of EUR 32.5 Million | For |
| E.13 | Authorize Issuance of Equity or Equity-Linked Securities without Pre-emptive Rights up to Aggregate Nominal Amount of EUR 6.5 Million | Oppose |
| E.14 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 6.5 Million | Oppose |
| E.15 | Approve Issuance of Equity or Equity-Linked Securities Reserved for Specific Beneficiaries, up to Aggregate Nominal Amount of EUR 6.5 Million | Oppose |
| E.16 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above | Oppose |
| E.17 | Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights | Oppose |
| E.18 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind | For |
| E.19 | Authorize Capitalization of Reserves of Up to EUR 32.5 Million for Bonus Issue or Increase in Par Value | For |
| E.20 | Authorize Capital Increase of Up to EUR 6.5 Million for Future Exchange Offers | For |
| E.21 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans | For |
| E.22 | Authorize up to 102,020 Preferred Shares (ADP 2) without Preemptive Rights Reserved for Corporate Officers and Employees | Oppose |
| E.23 | Authorize Decrease in Share Capital via Cancellation of Repurchased Shares | For |
| E.24 | Amend Article 15 of Bylaws Re: Written Consultation | For |
| E.25 | Authorize Filing of Required Documents/Other Formalities | For |
